{"nctId":"NCT01991860","briefTitle":"US Phase III Study of APD421 in PONV","startDateStruct":{"date":"2013-08"},"conditions":["PONV"],"count":364,"armGroups":[{"label":"APD421","type":"EXPERIMENTAL","interventionNames":["Drug: APD421- Amisulpride for IV injection"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"APD421- Amisulpride for IV injection","otherNames":["Amisulpride for IV injection"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female patients ≥ 18 years of age\n* Patients undergoing elective surgery (open or laparoscopic technique) under general anaesthesia, expected to last at least one hour from induction of anaesthesia to wound closure and expected to require at least one overnight stay in hospital\n\nExclusion Criteria:\n\n* Patients scheduled for outpatient/day case surgery\n* Patients scheduled to undergo intra-thoracic, transplant or central nervous system surgery\n* Patients scheduled to receive only a local anaesthetic/regional neuraxial (intrathecal or epidural) block\n* Patients who are expected to remain ventilated for a period after surgery\n* Patients who are expected to need a naso- or orogastric tube in situ after surgery is completed","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Complete Response","description":"The primary efficacy analysis was a comparison of the incidence of Complete Response, defined as no emesis (vomiting or retching) and no use of rescue medication in the 24 hours after the end of surgery, between the active group and the placebo group using Pearson χ2 test with Yates's continuity correction, and with a two-sided significance level of 5%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":null},{"groupId":"OG001","value":"54","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With no Nausea.","description":"Nausea (defined as the desire to vomit without the presence of expulsive muscular movements) measured on a 0-10 verbal response scale, where 0=no nausea at all and 10=the worst nausea imaginable. \"No nausea\" means no score ≥ 1.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"82","spread":null},{"groupId":"OG001","value":"64","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With no Emesis","description":"Emesis is defined as vomiting (production of even the smallest amount of stomach contents) or retching (muscular movements of vomiting but without expulsion of stomach contents, usually because of an empty stomach)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"141","spread":null},{"groupId":"OG001","value":"129","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With no Use of Rescue Medication","description":"Any agent given in the post-operative period with the intention of providing anti-emetic rescue was counted as rescue anti-emetic medication for the purposes of efficacy determination, even if it did not achieve control of emesis or was given incorrectly (e.g., wrong dosage or route). Any agent given in the post-operative period which would be expected, by virtue of its pharmacology, dosage and route, to exert a clinically meaningful anti-emetic effect was considered as rescue anti-emetic medication, even if administered inadvertently or without the intention of providing rescue.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null},{"groupId":"OG001","value":"55","spread":null}]}]}]},{"type":"SECONDARY","title":"The Number of Participants With no Emesis, no Significant Nausea and no Use of Rescue Medication","description":"No occurrence of vomiting/retching, no nausea score ≥ 4 on verbal response scale (where 0=no nausea at all and 10=the worst nausea imaginable) and no use of rescue medication.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73","spread":null},{"groupId":"OG001","value":"53","spread":null}]}]}]},{"type":"SECONDARY","title":"The Number of Participants With no Significant Nausea","description":"Nausea (defined as the desire to vomit without the presence of expulsive muscular movements) measured on a 0-10 verbal response scale, where 0=no nausea at all and 10=the worst nausea imaginable. \"No significant nausea\" means no score ≥ 4.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"107","spread":null},{"groupId":"OG001","value":"84","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With \"Total Response\"","description":"Total response is defined as no occurrence of vomiting/retching, no nausea score ≥ 1 and no use of rescue medication.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67","spread":null},{"groupId":"OG001","value":"50","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8,"n":176},"commonTop":["Procedural Pain","Hyperglycaemia","Anaemia Postoperative","Hypocalcaemia","Hypoproteinaemia"]}}}